ENTRY       D08493            Mixture   Drug
NAME        Dorzolamide hydrochloride and timolol maleate (JP18);
            Cosopt (TN)
PRODUCT     COSOPT (Akorn)
            COSOPT (Thea Pharma)
            COSOPT PF (Akorn)
            COSOPT PF (Thea Pharma)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Akorn)
  GENERIC   DORZOLAMIDE AND TIMOLOL (Leading Pharma)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (A-S Medication Solutions)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (A-S Medication Solutions)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Akorn)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Aurobindo Pharma Limited)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Bausch & Lomb Incorporated)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Gland Pharma Limited)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Golden State Medical Supply)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Ingenus Pharmaceuticals)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Micro Labs Limited)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Sandoz)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (Somerset Therapeutics)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION (Alembic Pharmaceuticals)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION (Micro Labs Limited)
            DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE (Aurobindo Pharma Limited)
            DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE (Biocon Pharma)
            DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE (Florida Pharmaceutical Products)
            DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE (Indoco Remedies Limited)
COMPONENT   Dorzolamide hydrochloride [DR:D00653], Timolol maleate [DR:D00603]
CLASS       Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
              DG03030  Combination of carbonic anhydrase inhibitor and beta blocker
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1319
            ATC code: S01ED51
            Product: D08493<JP/US>
EFFICACY    Antiglaucoma
  DISEASE   Open-angle glaucoma [DS:H00612]
COMMENT     carbonic anhydrase inhibitor / beta-blocker combination
            Dorzolamide is primarily metabolized by CYP2C9, CYP2C19 and CYP3A4.
            Timolol is primarily metabolized by CYP2D6.
METABOLISM  Enzyme: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01ED Beta blocking agents
                 S01ED51 Timolol, combinations
                  D08493  Dorzolamide hydrochloride and timolol maleate (JP18) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Agents, Combinations
               Dorzolamide Hydrochloride/ Timolol Maleate
                D08493  Dorzolamide hydrochloride and timolol maleate (JP18)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D08493  Dorzolamide hydrochloride and timolol maleate (JP18)
            Drug groups [BR:br08330]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG03030  Combination of carbonic anhydrase inhibitor and beta blocker
                D08493  Dorzolamide hydrochloride and timolol maleate
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               D08493  Dorzolamide hydrochloride and timolol maleate
              DG01639  CYP2C19 substrate
               D08493  Dorzolamide hydrochloride and timolol maleate
              DG01644  CYP2D6 substrate
               D08493  Dorzolamide hydrochloride and timolol maleate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D08493  Dorzolamide hydrochloride and timolol maleate
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D08493  Dorzolamide hydrochloride and timolol maleate
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D08493  Dorzolamide hydrochloride and timolol maleate ophthalmic solution
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08493
DBLINKS     PubChem: 124490301
///
